Literature DB >> 33899610

Hypoglycemia and seizures associated with canine primary hepatic neuroendocrine carcinoma.

Amanda R Dorn1, Alexandra Brower1, Hailey Turner1, Klayton Lapa2.   

Abstract

A 10-y-old intact male Labrador Retriever dog had a history of ataxia, inability to stand, and grand mal seizures. Complete blood count and serum biochemistry profiles revealed profound hypoglycemia, mildly increased alanine aminotransferase (ALT) activity, mild hypernatremia, and lymphopenia. The seizures could not be controlled with intravenous dextrose, diazepam, or propofol. The dog was euthanized given poor quality of life, and an autopsy was performed. Primary autopsy findings included firm hepatic masses that ranged from dark-red to tan, with the largest ~1.5 cm diameter, and pulmonary edema. Histologic examination of the hepatic masses revealed redundant, several-cell-thick cords, and packeted or acinar arrangements of polygonal cells, supported on a fibrovascular stroma. The neoplastic cells were immunopositive for insulin, synaptophysin, and neuron-specific enolase immunohistochemistry; granules in the tumor cells had an affinity for Grimelius silver stain. The histologic features, as well as the immunohistochemical staining profile, identified the neoplasm as a primary multifocal hepatic neuroendocrine carcinoma. Neuroendocrine carcinomas are rare in dogs and usually occur in the gastrointestinal or respiratory tract.

Entities:  

Keywords:  canine; carcinoid; hepatic neuroendocrine carcinoma; hypoglycemia; seizure

Mesh:

Substances:

Year:  2021        PMID: 33899610      PMCID: PMC8229821          DOI: 10.1177/10406387211012378

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  8 in total

1.  Paraneoplastic hypoglycemia due to an insulin-like growth factor type-II secreting hepatocellular carcinoma in a dog.

Authors:  Eric Zini; Tony M Glaus; Francesco Minuto; Marica Arvigo; Beat Hauser; Claudia E Reusch
Journal:  J Vet Intern Med       Date:  2007 Jan-Feb       Impact factor: 3.333

Review 2.  Hypoglycemia in dogs: Causes, management, and diagnosis.

Authors:  Olutunbi Idowu; Kathryn Heading
Journal:  Can Vet J       Date:  2018-06       Impact factor: 1.008

3.  Primary Hepatic Neuroendocrine Carcinoma Treated with Doxorubicin and Cyclophosphamide in a Dog.

Authors:  Elizabeth Morgan; Kathleen O'Connell; Maurine Thomson; Susan Boyd; Jeanine Sandy
Journal:  J Am Anim Hosp Assoc       Date:  2019-03-14       Impact factor: 1.023

4.  Carcinoid syndrome, acromegaly, and hypoglycemia due to an insulin-secreting neuroendocrine tumor of the liver.

Authors:  J Furrer; A Hättenschwiler; P Komminoth; T Pfammatter; P Wiesli
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

5.  Canine hepatic neuroendocrine carcinoma: an immunohistochemical and electron microscopic study.

Authors:  A K Patnaik; S J Newman; T Scase; R A Erlandson; C Antonescu; D Craft; P J Bergman
Journal:  Vet Pathol       Date:  2005-03       Impact factor: 2.221

6.  Improving the diagnosis and management of neuroendocrine tumors: utilizing new advances in biomarker and molecular imaging science.

Authors:  Valeria Giandomenico; Irvin M Modlin; Fredrik Pontén; Mats Nilsson; Ulf Landegren; Jonas Bergqvist; Mohid S Khan; Robert P Millar; Bengt Långström; Jürgen Borlak; Barbro Eriksson; Bengt Nielsen; Lars Baltzer; John C Waterton; Håkan Ahlström; Kjell Öberg
Journal:  Neuroendocrinology       Date:  2013-06-28       Impact factor: 4.914

7.  Primary giant hepatic neuroendocrine carcinoma: a case report.

Authors:  Aldo Rocca; Fulvio Calise; Giuseppina Marino; Stefania Montagnani; Mariapia Cinelli; Bruno Amato; Germano Guerra
Journal:  Int J Surg       Date:  2014-05-29       Impact factor: 6.071

8.  Primary hepatic carcinoid tumor: a case report and review of the literature.

Authors:  Chih-Wen Lin; Chung-Hsu Lai; Chia-Chang Hsu; Chao-Tien Hsu; Pei-Min Hsieh; Kuo-Chen Hung; Yaw-Sen Chen
Journal:  Cases J       Date:  2009-01-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.